Breaking News Instant updates and real-time market news.

MNK

Mallinckrodt

$36.12

-5.05 (-12.27%)

, PX

Praxair

$130.30

-0.73 (-0.56%)

07:39
09/06/17
09/06
07:39
09/06/17
07:39

Mallinckrodt downgraded after Inomax ruling at Morgan Stanley

As previously reported, Morgan Stanley analyst David Risinger downgraded Mallinckrodt to Equal Weight from Overweight as he believes yesterday's unfavorable district court ruling in Mallinckrodt's (MNK) suit against Praxair (PX) has increased the risk of an Inomax generic potentially as soon as October 2018, compared to his prior expectation of 2031. The analyst, who thinks heightened Acthar concentration and Generics segment pressures limit the stock's upside potential, lowered his price target on Mallinckrodt shares to $40 from $65.

MNK

Mallinckrodt

$36.12

-5.05 (-12.27%)

PX

Praxair

$130.30

-0.73 (-0.56%)

  • 06

    Sep

  • 06

    Sep

  • 11

    Sep

MNK Mallinckrodt
$36.12

-5.05 (-12.27%)

09/05/17
RAJA
09/05/17
NO CHANGE
RAJA
Outperform
Mallinckrodt selloff discounts competitive INOmax impact, says Raymond James
Raymond James analyst Elliot Wilbur said the selloff in Mallinckrodt fully discounts the negative financial impact of the ompetitive version of INOmax and would use weakness as a an opportunity to accumulate shares. Wilbur rates Mallinckrodt an Outperform.
09/05/17
BMOC
09/05/17
NO CHANGE
BMOC
Outperform
Mallinckrodt news on Inomax comes at difficult time, says BMO Capital
BMO Capital analyst Gary Nachman said Mallinckrodt (MNK) was surprised that a district court ruled in favor of Praxair (PX), invalidating five HF patents and ruling Praxair does not infringe other patents related to Inomax given its previous successes with these patents in the IPR process. Nachman said the news comes at a time when investors are already worried about Acthar concentration risk and the durability of Mallinckrodt's portfolio and only adds to those concerns. However, the analyst, who sees management considering more aggressive ways to try and unlock shareholder value, keeps an Outperform rating on Mallinckrodt shares.
09/06/17
MSCO
09/06/17
DOWNGRADE
MSCO
Equal Weight
Mallinckrodt downgraded to Equal Weight from Overweight at Morgan Stanley
09/06/17
DBAB
09/06/17
NO CHANGE
Target $56
DBAB
Buy
Court ruling brings 'important new risk' to Mallinckrodt, says Deutsche Bank
Deutsche Bank analyst Gregg Gilbert believes yesterday's ruling in Mallinckrodt's (MNK) non-infringement case against Praxair (PX) on Inomax is a negative surprise and "represents an important new risk." The analyst had assumed based on prior legal news flow that Mallinckrodt's intellectual property for the product was on "solid ground." The analyst notes that while an appeal could take some time to play out, generic competition to Inomax is not factored into his estimates, target or rating. As such, a generic hit could "materially affect" estimates, Gilbert tells investors in a research note. The analyst keeps a Buy rating on Mallinckrodt, citing valuation following yesterday's selloff.
PX Praxair
$130.30

-0.73 (-0.56%)

06/09/17
JPMS
06/09/17
NO CHANGE
Target $156
JPMS
Overweight
Praxair price target raised to $156 from $130 at JPMorgan
JPMorgan analyst Jeffrey Zekauskas raised his price target for Praxair to $156 saying the merger with Linde "should create shareholder value over a longer period of time." The analyst finds it reasonable to expect the new company's margins will be "meaningfully higher" than the current EBITDA margins of Praxair because of scale considerations. He keeps an Overweight rating on Praxair shares.
08/10/17
JEFF
08/10/17
NO CHANGE
Target $162
JEFF
Buy
Praxair added to Franchise Picks list at Jefferies
Jefferies analyst Laurence Alexander added Praxair to his firm's Franchise Picks list saying the risk/reward is attractive at current share levels. A turn in the industrials capex cycle would be a "significant positive" for the industrial gas companies over the next 12-18 months, Alexander tells investors in a research note. Even absent one, the merger gives Praxair a path to double by 2020, the analyst adds. He keeps a Buy rating on the shares with a $162 price target.
09/05/17
JPMS
09/05/17
NO CHANGE
JPMS
Neutral
Mallinckrodt selloff on court decision looks overdone, says JPMorgan
JPMorgan analyst Chris Schott says that while today's decision by the District Court of Delaware on Inomax is a setback, the corresponding selloff in shares of Mallinckrodt (MNK) appears overdone. Inomax is one of Mallinckrodt's least controversial assets and the Street broadly assumes patent protection and growth for the product out to 2030-plus, Schott tells investors in an intraday research note. However, the analyst adds that the timing of potential generic competition is "far from clear" with Mallinckrodt appealing today's verdict in favor of Praxair (PX). Further, Schott only sees "gradual erosion" to the Inomax franchise once a competitor enters the market. Nonetheless, he keeps a Neutral rating on Mallinckrodt shares. The stock in afternoon trading is down 12%, or $4.81, to $36.36.
09/05/17
STFL
09/05/17
NO CHANGE
Target $85
STFL
Buy
Mallinckrodt INOmax fight 'far from over,' says Stifel
Stifel analyst Annabel Samimy said the threat to Mallinckrodt's (MNK) INOmax is not as significant as today's reaction in the stock would suggest, noting that not only will Mallinckrodt likely appeal the district court's patent ruling but it also has another outstanding lawsuit related to the system that includes other patents. Beyond all of that, Samimy said Praxair (PX) does not have its own drug/device approved yet and the company will have to negotiate new contracts for hospitals to uninstall the INOmax system and install its platform, leading him to keep a Buy rating and $85 price target on Mallinckrodt shares, which are down 12% to $36.25 in afternoon trading.

TODAY'S FREE FLY STORIES

TSLA

Tesla

$315.05

2.55 (0.82%)

10:21
11/18/17
11/18
10:21
11/18/17
10:21
Periodicals
Tesla new super car to cost $200,000, Recode says »

Alongside its new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 16

    Jan

GT

Goodyear Tire

$29.94

0.63 (2.15%)

10:17
11/18/17
11/18
10:17
11/18/17
10:17
Hot Stocks
Goodyear Tire, NASCAR extend relationship »

NASCAR and Goodyear Tire…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 09

    Jan

  • 16

    Jan

HMC

Honda

$32.62

0.02 (0.06%)

10:05
11/18/17
11/18
10:05
11/18/17
10:05
Periodicals
Honda recalls 900,000 minivans on tip forward seats, Reuters says »

Honda Motor is recalling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$88.43

-0.82 (-0.92%)

09:48
11/18/17
11/18
09:48
11/18/17
09:48
Periodicals
Activist investors Nelson Peltz still in P&G picture, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHGE

Baker Hughes

$30.91

0.76 (2.52%)

, GE

General Electric

$18.21

-0.04 (-0.22%)

09:39
11/18/17
11/18
09:39
11/18/17
09:39
Periodicals
Buy Baker Hughes, Barron's says »

While it is "not…

BHGE

Baker Hughes

$30.91

0.76 (2.52%)

GE

General Electric

$18.21

-0.04 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

CSCO

Cisco

$35.90

0.02 (0.06%)

09:19
11/18/17
11/18
09:19
11/18/17
09:19
Periodicals
More needed for Cisco to have 'groove back,' Barron's says »

While the Nasdaq…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

  • 11

    Dec

  • 17

    Jan

  • 17

    Jan

IBM

IBM

$148.97

-0.15 (-0.10%)

09:10
11/18/17
11/18
09:10
11/18/17
09:10
Periodicals
IBM could be next to fetch higher valuation, Barron's says »

Investors are warming to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

GE

General Electric

$18.21

-0.04 (-0.22%)

09:05
11/18/17
11/18
09:05
11/18/17
09:05
Periodicals
Option play offer some help given GE dividend, depressed stock, Barron's says »

While wagering against…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$18.21

-0.04 (-0.22%)

09:00
11/18/17
11/18
09:00
11/18/17
09:00
Periodicals
Risk remains after GE dividend cut, Barron's says »

While buying General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$88.72

0.71 (0.81%)

, T

AT&T

$34.51

-0.01 (-0.03%)

08:21
11/18/17
11/18
08:21
11/18/17
08:21
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

TWX

Time Warner

$88.72

0.71 (0.81%)

T

AT&T

$34.51

-0.01 (-0.03%)

NYT

New York Times

$17.65

0.05 (0.28%)

TEX

Terex

$44.82

0.8 (1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

TPIC

TPI Composites

$19.06

-0.97 (-4.84%)

07:25
11/18/17
11/18
07:25
11/18/17
07:25
Conference/Events
TPI Composites to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SYNA

Synaptics

$38.21

0.57 (1.51%)

04:55
11/18/17
11/18
04:55
11/18/17
04:55
Conference/Events
Synaptics management to meet with KeyBanc »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

, BRCD

Brocade

18:01
11/17/17
11/17
18:01
11/17/17
18:01
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

BRCD

Brocade

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

AVGO

Broadcom

$271.86

-0.25 (-0.09%)

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

LMOS

Lumos Networks

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 06

    Dec

WGL

WGL Holdings

$84.32

-0.14 (-0.17%)

18:01
11/17/17
11/17
18:01
11/17/17
18:01
Earnings
WGL Holdings reports Q4 adjusted EPS (17c), consensus (19c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

, LMOS

Lumos Networks

17:58
11/17/17
11/17
17:58
11/17/17
17:58
Hot Stocks
Tactile Systems to replace Lumos Networks in S&P 600 at open on 11/22 »

EQT Infrastructure…

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

LMOS

Lumos Networks

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

, MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

17:56
11/17/17
11/17
17:56
11/17/17
17:56
Hot Stocks
Breaking Hot Stocks news story on Invesco Mortgage, MKS Instruments »

Invesco Mortgage to…

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

, BRCD

Brocade

17:55
11/17/17
11/17
17:55
11/17/17
17:55
Hot Stocks
MKS Instruments to replace Brocade in S&P 400 at open on 11/22 »

S&P 500 constituent…

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

BRCD

Brocade

AVGO

Broadcom

$271.86

-0.25 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

UQM

UQM Technologies

$1.18

0.015 (1.29%)

17:24
11/17/17
11/17
17:24
11/17/17
17:24
Syndicate
Breaking Syndicate news story on UQM Technologies »

UQM Technologies files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$238.02

-1.35 (-0.56%)

17:23
11/17/17
11/17
17:23
11/17/17
17:23
Periodicals
Goldman Sachs has $510M lawsuit dismissed, Reuters reports »

A $510M lawsuit that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VICL

Vical

$1.94

-0.02 (-1.02%)

17:18
11/17/17
11/17
17:18
11/17/17
17:18
Hot Stocks
Breaking Hot Stocks news story on Vical »

Biotechnology Value Fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$140.31

-1.4 (-0.99%)

17:18
11/17/17
11/17
17:18
11/17/17
17:18
Hot Stocks
Ligand director sells 5,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$140.31

-1.4 (-0.99%)

17:17
11/17/17
11/17
17:17
11/17/17
17:17
Hot Stocks
Ligand CFO sells 6,559 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$140.31

-1.4 (-0.99%)

17:17
11/17/17
11/17
17:17
11/17/17
17:17
Hot Stocks
Ligand CEO sells 5,269 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBI

MBIA

$9.01

0.13 (1.46%)

17:15
11/17/17
11/17
17:15
11/17/17
17:15
Hot Stocks
Breaking Hot Stocks news story on MBIA »

Fine Capital Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBCN

Rubicon

$8.07

0.1218 (1.53%)

17:03
11/17/17
11/17
17:03
11/17/17
17:03
Hot Stocks
Breaking Hot Stocks news story on Rubicon »

Bandera Partners reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.